Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/53166

language	eng
Author	Yamaguchi Motoko Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan SUZUKI, Ritsuro Kim Seok Jin Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Ko Young Hyeh Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Oguchi Masahiko Department of Radiation Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan Asano Naoko Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan Miyazaki Kana Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan Terui Yasuhiko Department of Hematology and Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan Kubota Nobuko Division of Hematology, Saitama Cancer Center, Ina, Japan Maeda Takeshi Department of Hematology and Oncology, Kurashiki Central Hospital, Kurashiki, Japan Kobayashi Yukio Hematology Division, National Cancer Center Hospital, Tokyo, Japan Amaki Jun Division of Hematology & Oncology, Tokai University School of Medicine, Isehara, Japan Soejima Toshinori Department of Radiation Oncology, Hyogo Cancer Center, Akashi, Japan Saito Bungo Division of Hematology, Showa University School of Medicine, Tokyo, Japan Shimoda Emiko Department of Radiation Oncology, Nara Medical University, Kashihara, Japan Fukuhara Noriko Department of Hematology & Rheumatology, Tohoku University Hospital, Sendai, Japan Tsukamoto Norifumi Oncology Center, Gunma University Hospital, Maebashi, Japan Shimada Kazuyuki Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Choi Ilseung Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan Utsumi Takahiko Department of Hematology, Shiga Medical Center for Adults, Moriyama, Japan Ejima Yasuo Department of Radiology, Dokkyo Medical University, Shimotsuga, Japan Kim Won Seog Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Katayama Naoyuki Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
Subject	concurrent chemoradiotherapy; early progression; Epstein-Barr virus; NK; T-cell lymphoma; soluble interleukin-2 receptor
Journal Title	CANCER SCIENCE
Volume	109
Issue	6
Start Page	2056
End Page	2062
ISSN	1347-9032
ISSN（Online）	1349-7006
Published Date	2018-06
DOI	10.1111/cas.13597
PubMed ID	29601137
Publisher	WILEY
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	We thank the patients and doctors at the participating institutes (Appendix I) for their invaluable contributions to this cooperative study. This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (JSPS KAKENHI, grant numbers 26461418, 17K09924).